Prenetics Global Limited (PRE)
| Market Cap | 54.00M |
| Revenue (ttm) | 22.66M |
| Net Income (ttm) | -49.81M |
| Shares Out | 12.22M |
| EPS (ttm) | -4.13 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 418 |
| Open | 4.420 |
| Previous Close | 4.610 |
| Day's Range | 4.420 - 4.420 |
| 52-Week Range | 2.850 - 7.840 |
| Beta | -0.21 |
| Analysts | Buy |
| Price Target | 9.00 (+103.62%) |
| Earnings Date | Dec 3, 2024 |
About PRE
Prenetics Global Limited, a health sciences company, focuses on advancing consumer and clinical health. The company’s consumer initiatives is led by IM8, a new health and wellness brand. Its prevention arm, CircleDNA, uses next-generation sequencing (NGS) technology to offer comprehensive consumer DNA test. It also develops and commercializes multi-cancer early detection technologies. In addition, the company offers a range of genomic profiling panels tailored for requirements and clinician needs, including ACTOnco, ACT HRD, ACTFusion, and ACTD... [Read more]
Financial Performance
In 2023, Prenetics Global's revenue was $21.74 million, an increase of 65.17% compared to the previous year's $13.16 million. Losses were -$62.72 million, -67.07% less than in 2022.
Financial StatementsAnalyst Forecast
According to one analyst, the rating for PRE stock is "Buy" and the 12-month stock price forecast is $9.0.
News
MULTIMEDIA UPDATE -- Nasdaq-Listed Prenetics and David Beckham Officially Launch IM8 Health
Beckham is a strategic investor in Prenetics and Co-Founding Partner for IM8 IM8 launch marks a bold entry into the $187 billion global consumer health market Launch follows recently announced Preneti...
Nasdaq-Listed Prenetics and David Beckham Officially Launch IM8 Health
Beckham is a strategic investor in Prenetics and Co-Founding Partner for IM8 IM8 launch marks a bold entry into the $187 billion global consumer health market Launch follows recently announced Preneti...
Prenetics Announces Participation in the Sidoti Virtual Micro Cap Investor Conference
CHARLOTTE, N.C., Oct. 30, 2024 (GLOBE NEWSWIRE) -- Prenetics, (NASDAQ: PRE) a leading health sciences company, announced today that management will participate in the Sidoti Virtual Micro Cap Conferen...
Prenetics Announces Acquisition of Europa Sports Partners in Strategic Expansion to Consumer Health and Wellness Industry
Europa Is One of the Largest Sports Nutrition Distributors With a Network of 10,000+ Gyms Across the United States Supports Prenetics' New Health and Wellness Brand IM8 with David Beckham as its Co-Fo...
Prenetics, NASDAQ Health Sciences Company, Partners with David Beckham
LOS ANGELES, July 11, 2024 (GLOBE NEWSWIRE) -- Prenetics, (NASDAQ: PRE) a leading health sciences company, is proud to announce that former international footballer, entrepreneur and philanthropist Da...
Prenetics Welcomes Kathyrn M. Henry and David Vanderveen to Board of Directors
Adding Decades of Public Company and Board Expertise as Prenetics Readies for Expansion into Consumer Health and Wellness Adding Decades of Public Company and Board Expertise as Prenetics Readies for ...
Prenetics Announces First Quarter 2024 Financial Results
First Quarter Revenue Increased 30.2% and Gross Profit Increased 159.8% from Prior Year Quarter
Prenetics Announces Fourth Quarter and Full Year 2023 Financial Results
HONG KONG, April 01, 2024 (GLOBE NEWSWIRE) -- Prenetics Global Limited (NASDAQ: PRE) (“Prenetics” or the “Company”), a leading genomics-driven health sciences company, today announced unaudited financ...
Prenetics Announces MOU for a Strategic Investment and 5-Year Research Collaboration with Metavisionaries to Pioneer R&D on the International Space Station
(From left: Dr. Ghada Alsaleh, Sonia Pawelczyk, Danny Yeung, Dr. James L. Green, Ahmed Alfandi, Dr. Tara Ruttley, Wasim Ahmed, Dr. Hilde Stenuit, Dr. Camille Alleyne at the MOU signing ceremony in Dub...
Prenetics Announces Third Quarter 2023 Financial Results
HONG KONG, Nov. 20, 2023 (GLOBE NEWSWIRE) -- Prenetics Global Limited (NASDAQ: PRE) (“Prenetics” or the “Company”), a leading genomics-driven health sciences company, today announced financial results...
Prenetics Global Limited Announces Reverse Stock Split
HONG KONG, Nov. 01, 2023 (GLOBE NEWSWIRE) -- Prenetics Global Limited (NASDAQ: PRE), a leading-genomics-driven health sciences company today announced that it will proceed with a reverse stock split o...
Prenetics Announces Second Quarter 2023 Financial Results
HONG KONG, Sept. 15, 2023 (GLOBE NEWSWIRE) -- Prenetics Global Limited (NASDAQ: PRE) (“Prenetics” or the “Company”), a leading genomics-driven health sciences company, today announced financial result...
Prenetics CEO discusses $200 million JV for early cancer detection breakthrough
Danny Yeung, CEO of Hong Kong's genetics testing firm Prenetics, speaks about the $200 million joint venture that his company has formed with professor Dennis Lo from Chinese University of Hong Kong, ...
Prenetics and Globally Renowned Scientist Prof. Dennis Lo Establish US$200m Joint Venture “Insighta” for Breakthrough Multi-Cancer Early Detection Screening
Company will Host Conference Call to Discuss the Transaction on June 26 at 8:30 a.m. EDT Company will Host Conference Call to Discuss the Transaction on June 26 at 8:30 a.m. EDT
Prenetics Announces First Quarter 2023 Financial Results
HONG KONG, June 05, 2023 (GLOBE NEWSWIRE) -- Prenetics Global Limited (NASDAQ: PRE) (“Prenetics” or the “Company”), a leading genomics and precision oncology company, today announced financial results...
Prenetics Announces Fourth Quarter and Full Year 2022 Financial Results
New Business Strategy Focused on Precision Oncology New Business Strategy Focused on Precision Oncology
Prenetics Announces Formation of Scientific Advisory Board to Support New Business Strategy in Precision Oncology
LONDON and HONG KONG, March 02, 2023 (GLOBE NEWSWIRE) -- Prenetics Global Limited (NASDAQ: PRE), a leader in genomic and diagnostic testing, is proud to announce the formation of a new Prenetics Scien...
Prenetics to Participate Virtually at the BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference
LONDON and HONG KONG, Feb. 02, 2023 (GLOBE NEWSWIRE) -- Prenetics Global Limited (NASDAQ: PRE), a leader in genomic and diagnostic testing, today announced that its management team will participate vi...
Prenetics Announces Dr. Bayju Thakar as Chief Executive Officer of Prenetics EMEA
LONDON and HONG KONG, Jan. 19, 2023 (GLOBE NEWSWIRE) -- Prenetics Global Limited (NASDAQ: PRE) a leader in genomic and diagnostic testing, today announced an executive leadership change to ensure the ...
Prenetics Global's stock rallies 82%
Shares of Prenetics Global Ltd. PRE, -2.11% jumped about 82% in premarket trading on Tuesday after the company said ActOnco's genomic test for tumors recently received clearance from the Food and Drug...
Prenetics Owned ACT Genomics Receives FDA Clearance for ACTOnco, the First Asia-Based Company to Receive Clearance for a Comprehensive Genomic Profiling Test for All Solid Tumors
LONDON and HONG KONG, Jan. 10, 2023 (GLOBE NEWSWIRE) -- Prenetics Global Limited (NASDAQ: PRE) a leader in genomic and diagnostic testing, today announced that ACT Genomics, a company which Prenetics ...
Prenetics Acquires ACT Genomics, Creating a Leader in Comprehensive Cancer Genetics and Precision Oncology
LONDON and HONG KONG, Dec. 16, 2022 (GLOBE NEWSWIRE) -- Prenetics Global Limited (NASDAQ: PRE), a leader in genomic and diagnostic testing, today announced that it is acquiring a majority stake in ACT...
Prenetics Announces US$20 Million Stock Repurchase Program and Inclusion into the MSCI Global Micro Cap Index
LONDON and HONG KONG, Nov. 30, 2022 (GLOBE NEWSWIRE) -- Prenetics Global Limited (NASDAQ: PRE) (“Prenetics” or the “Company”), a global leader in genomic and diagnostic testing, today announced that i...
Prenetics Announces Record Third Quarter 2022 Financial Results and Raises Full Year 2022 Revenue and EBITDA Guidance
LONDON and HONG KONG, Nov. 10, 2022 (GLOBE NEWSWIRE) -- Prenetics Global Limited (NASDAQ: PRE) (“Prenetics” or the “Company”), a global leader in genomic and diagnostic testing, today announced its un...
Prenetics Announces Second Quarter 2022 Financial Results and Raises Full Year Adjusted EBITDA Outlook
LONDON and HONG KONG, Sept. 09, 2022 (GLOBE NEWSWIRE) -- Prenetics Global Limited (NASDAQ: PRE) (“Prenetics” or the “Company”), a global leader in genomic and diagnostic testing, today announced its u...